您好,欢迎来到上海士研管理咨询有限公司
士研峰会 士研智库 士研调研
嘉宾信息
尹正
尹正
所属职位: 管理合伙人
所属公司:

三一创新(北京)投资管理公司

三一创新(北京)投资管理公司是一家专注在生物医药创新领域的投资机构。创办三一创新(北京)投资管理公司之前,尹正博士曾任国投创新投资管理公司董事总经理,专注生物医药行业股权投资,主要投资项目有迪哲、亚盛、康希诺、瑞博、信达、博瑞等。尹正博士在生物医药领域积累了多层次、丰富的行业经验,在国外工作期间先后服务于生物技术公司与大型跨国制药企业Novartis,负责新药创制与项目管理;回国后在国内著名高等学府从事与生物医药相关的教学、科研、管理和咨询等工作,曾任南开大学药学院院长、药物化学生物学国家重点实验室副主任、清华大学基础分子科学中心执行主任等职务;受聘为多个国家级行业与科技专业委员会的成员。尹正博士还曾担任普华永道投资与并购咨询业务总监,开展生物医药行业投资与并购咨询业务。尹正博士拥有南开大学学士学位和硕士学位,新加坡国立大学理学博士学位 Trinity Innovation (Beijing) Investment Management Co., Ltd is an investment institution focusing on the field of biomedical innovation. Before starting the company, Dr. Yin Served as the managing director of SDIC Innovation Investment Management Co., Ltd., responsible for equity investment in the pharmaceutical and healthcare sector, such as Dizal, Ribo, Ascentage, CanSino, Bright-gene, Ribo and EpimAb. Dr. Yin Worked in both biotech and global multinational pharmaceutical companies Novartis,  responsible for innovative drug discovery and project management; Previous positions include Dean of the School of Pharmacy of Nankai University, Deputy Director of the State Key Laboratory of Medicinal Chemical Biology, and Executive Director of the Center for Basic Molecular Science of Tsinghua University. He has been employed as a member of several national industry and science and technology professional committees. Dr. Yin Zheng also served as the PWC Investment and M&A of Consulting Director, and carried out investment and M &A consulting business in the Biomedical Industry.Bachelor and Master degree from Nankai University; Ph.D. of Science, National University of Singapore. 

微信公众号
领导者网络APP
友情链接
Copyright ©2005 - 2017上海士研管理咨询有限公司
犀牛云提供企业云服务